tiprankstipranks
Blurbs

Analysts’ Top Healthcare Picks: Amedisys (AMED), United Therapeutics (UTHR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amedisys (AMEDResearch Report), United Therapeutics (UTHRResearch Report) and Applied Molecular Transport (AMTIResearch Report) with bullish sentiments.

Amedisys (AMED)

Jefferies analyst Brian Tanquilut maintained a Buy rating on Amedisys yesterday and set a price target of $200.00. The company’s shares closed last Thursday at $115.06, close to its 52-week low of $109.53.

According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 3.8% and a 51.1% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Privia Health Group, Oak Street Health, and 1Life Healthcare.

Currently, the analyst consensus on Amedisys is a Moderate Buy with an average price target of $176.63.

See the top stocks recommended by analysts >>

United Therapeutics (UTHR)

Jefferies analyst Eun Yang maintained a Buy rating on United Therapeutics yesterday and set a price target of $245.00. The company’s shares closed last Thursday at $221.16.

According to TipRanks.com, Yang is a 4-star analyst with an average return of 3.2% and a 46.9% success rate. Yang covers the Healthcare sector, focusing on stocks such as Centessa Pharmaceuticals, Aerovate Therapeutics, and Taysha Gene Therapies.

United Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $254.75.

Applied Molecular Transport (AMTI)

Jefferies analyst Chris Howerton maintained a Buy rating on Applied Molecular Transport yesterday and set a price target of $74.00. The company’s shares closed last Thursday at $4.06, close to its 52-week low of $2.80.

According to TipRanks.com, Howerton ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -19.0% and a 27.4% success rate. Howerton covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Finch Therapeutics Group, and Prometheus Biosciences.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Applied Molecular Transport with a $48.33 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AMED:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed